Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/46495
Title: Clinical characteristics, quality of life and risk factors for severity in palmoplantar pustulosis: a cross-sectional, multicentre study of 263 patients
Authors: Solak, S. Sarikaya
Polat, A. Kara
Kilic, S.
Topal, I. Oguz
Saricaoglu, H.
Karadag, A. S.
Canpolat, F.
Kartal, S. P.
Deveci, B. N.
Kacar, N.
Ekinci, A. Polat
Guner, R.
Polat, M.
Dogan, G.
Ozden, M. Guler
Baskan, E. Bulbul
Yavuz, G. Ozaydin
Adisen, E.
Gulekon, A.
Tanribilir, M. E.
Yilmaz, O.
Karakas, A. Akman
Ozturk, P.
Balci, D. Didar
Gonulal, M.
Yondem, H.
Ermertcan, A. Turel
Sendur, N.
Topyildiz, H.
Korkmaz, S.
Alpsoy, E.
Keywords: Psoriasis
Comorbidities
Plantaris
Palmaris
Publisher: Wiley
Abstract: Background Palmoplantar pustulosis (PPP) is a rare, chronic, inflammatory skin disease characterized by sterile pustules on palmar or plantar areas. Data on PPP are scarce. Aim To investigate the clinical characteristics and risk factors for disease severity in a large cohort of Turkish patients with PPP. Methods We conducted a cross-sectional, multicentre study of patients with PPP recruited from 21 tertiary centres across Turkey. Results In total, 263 patients (165 women, 98 men) were evaluated. Most patients (75.6%) were former or current smokers. The mean Palmoplantar Pustulosis Area and Severity Index (PPPASI) was 8.70 +/- 8.06 and the mean Dermatology Life Quality Index (DLQI) score was 6.87 +/- 6.08, and these scores were significantly correlated (r = 0.52, P < 0.001). Regression analysis showed that current smoking was significantly associated with increased PPPASI (P = 0.03). Coexisting psoriasis vulgaris (PsV) was reported by 70 (26.6%) patients. Male sex prevalence, PPP onset incidence, disease duration, DLQI, and prevalence of nail involvement and psoriatic arthritis (PsA) were significantly increased among patients with PPP with PsV. Of the 263 patients, 18 (6.8%) had paradoxical PPP induced by biologic therapy, and these patients had significantly increased mean DLQI and prevalence of PsA (r = 0.03, P = 0.001). Conclusion Our data suggest that smoking is a risk factor for both PPP development and disease severity. Patients with PPP with PsV present distinct clinical features and patients with biologic therapy-induced paradoxical PPP have reduced quality of life and are more likely to have PsA.
URI: https://doi.org/10.1111/ced.14829
https://hdl.handle.net/11499/46495
ISSN: 0307-6938
1365-2230
Appears in Collections:PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection

Show full item record



CORE Recommender

SCOPUSTM   
Citations

12
checked on Dec 14, 2024

WEB OF SCIENCETM
Citations

11
checked on Dec 20, 2024

Page view(s)

54
checked on Aug 24, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.